Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
17-7-1|n/a,n/a|1|900|none (controls)||unit code not relevant|not applicable or not supplied|carrier autologous serum for 21 days starting one day after exposure|3 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|Sacrifice after 360 d, different hematological parameters including determinations of GM-CFC in the bone marrow and the blood, colony stimulating activity (CSA), chGM-CSF and anti rhGM-CSF antibodies in the seriuml sequential studies over 1 year after exposure|No information on individuals available for this study
17-7-2|n/a,n/a|1|900|colony stimulat. factor|10|milligrams per g animal|Injection, subcutaneously|rhGM-CSF 10g/kg 2times /d for 21 days starting 1 day after exposure|2 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|Sacrifice after 360 d, different hematological parameters including determinations of GM-CFC in the bone marrow and the blood, colony stimulating activity (CSA), chGM-CSF and anti rhGM-CSF antibodies in the seriuml sequential studies over 1 year after exposure|No information on individuals available for this study
17-7-3|n/a,n/a|1|900|colony stimulat. factor|30|milligrams per g animal|Injection, subcutaneously|rhGM-CSF 30g/kg 2times /d for 21 days starting 1 day after exposure|2 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|Sacrifice after 360 d, different hematological parameters including determinations of GM-CFC in the bone marrow and the blood, colony stimulating activity (CSA), chGM-CSF and anti rhGM-CSF antibodies in the seriuml sequential studies over 1 year after exposure|No information on individuals available for this study
17-7-4|n/a,n/a|1|900|X-rays whole body|2.4|grays|External exposure|age 12-48 months|4 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|Sacrifice after 360 d, different hematological parameters including determinations of GM-CFC in the bone marrow and the blood, colony stimulating activity (CSA), chGM-CSF and anti rhGM-CSF antibodies in the seriuml sequential studies over 1 year after exposure|No information on individuals available for this study
17-7-4|n/a,n/a|2|900|none (controls)||unit code not relevant|not applicable or not supplied|carrier autologous serum for 21 days starting one day after exposure|4 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|Sacrifice after 360 d, different hematological parameters including determinations of GM-CFC in the bone marrow and the blood, colony stimulating activity (CSA), chGM-CSF and anti rhGM-CSF antibodies in the seriuml sequential studies over 1 year after exposure|No information on individuals available for this study
17-7-5|n/a,n/a|1|900|X-rays whole body|2.4|grays|External exposure|age 12-48 months|2 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|Sacrifice after 360 d, different hematological parameters including determinations of GM-CFC in the bone marrow and the blood, colony stimulating activity (CSA), chGM-CSF and anti rhGM-CSF antibodies in the seriuml sequential studies over 1 year after exposure|No information on individuals available for this study
17-7-5|n/a,n/a|2|900|colony stimulat. factor|10|milligrams per g animal|Injection, subcutaneously|rhGM-CSF 10g/kg 2times /d for 21 days starting 1 day after exposure|2 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|Sacrifice after 360 d, different hematological parameters including determinations of GM-CFC in the bone marrow and the blood, colony stimulating activity (CSA), chGM-CSF and anti rhGM-CSF antibodies in the seriuml sequential studies over 1 year after exposure|No information on individuals available for this study
17-7-6|n/a,n/a|1|900|X-rays whole body|2.4|grays|External exposure|age 12-48 months|2 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|Sacrifice after 360 d, different hematological parameters including determinations of GM-CFC in the bone marrow and the blood, colony stimulating activity (CSA), chGM-CSF and anti rhGM-CSF antibodies in the seriuml sequential studies over 1 year after exposure|No information on individuals available for this study
17-7-6|n/a,n/a|2|900|colony stimulat. factor|30|milligrams per g animal|Injection, subcutaneously|rhGM-CSF 30g/kg 2times /d for 21 days starting 1 day after exposure|2 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|Sacrifice after 360 d, different hematological parameters including determinations of GM-CFC in the bone marrow and the blood, colony stimulating activity (CSA), chGM-CSF and anti rhGM-CSF antibodies in the seriuml sequential studies over 1 year after exposure|No information on individuals available for this study
